Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
Meta Platforms (Facebook)
META
|
+$446M |
| 3 |
Johnson & Johnson
JNJ
|
+$306M |
| 4 |
Evergy
EVRG
|
+$288M |
| 5 |
Walmart Inc
WMT
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$596M |
| 2 |
Booking.com
BKNG
|
+$519M |
| 3 |
Amazon
AMZN
|
+$518M |
| 4 |
Eli Lilly
LLY
|
+$268M |
| 5 |
UnitedHealth
UNH
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.51% |
| 2 | Technology | 14.39% |
| 3 | Financials | 11.76% |
| 4 | Consumer Discretionary | 9.46% |
| 5 | Real Estate | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
First Business Financial Services
FBIZ
$565M
| $5.35M | 0.01% |
205,905
+39,505
| +24% | +$1.02M |
|
|
RAVN
1752
DELISTED
Raven Industries Inc
RAVN
| $5.35M | 0.01% |
139,200
+12,200
| +10% | +$467K |
|
1753
ACI Worldwide
ACIW
$6.12B
| $5.34M | 0.01% |
216,633
-243,900
| -53% | -$5.94M |
|
1754
OSI Systems
OSIS
$3.53B
| $5.34M | 0.01% |
69,016
+50,708
| +277% | +$3.54M |
|
1755
Marchex
MCHX
$77.8M
| $5.32M | 0.01% |
1,737,734
+38,334
| +2% | +$107K |
|
1756
Federal Signal
FSS
$6.82B
| $5.29M | 0.01% |
227,300
-81,500
| -26% | -$1.9M |
|
|
HT
1757
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $5.29M | 0.01% |
246,800
+154,900
| +169% | +$3.09M |
|
|
DNR
1758
DELISTED
Denbury Resources, Inc.
DNR
| $5.28M | 0.01% |
1,098,235
+591,900
| +117% | +$2.22M |
|
1759
GSI Technology
GSIT
$201M
| $5.28M | 0.01% |
702,100
+15,600
| +2% | +$118K |
|
|
KANG
1760
DELISTED
iKang Healthcare Group, Inc.
KANG
| $5.27M | 0.01% |
257,360
+212,800
| +478% | +$4.29M |
|
1761
Black Stone Minerals
BSM
$3.14B
| $5.26M | 0.01% |
284,755
+264,628
| +1,315% | +$4.76M |
|
|
INOV
1762
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $5.26M | 0.01% |
529,800
+51,500
| +11% | +$533K |
|
1763
Designer Brands
DBI
$315M
| $5.25M | 0.01% |
203,330
-510,700
| -72% | -$12.2M |
|
|
MCRN
1764
DELISTED
Milacron Holdings Corp.
MCRN
| $5.25M | 0.01% |
277,100
-343,600
| -55% | -$6.78M |
|
|
SRRA
1765
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $5.23M | 0.01% |
44,173
-1,660
| -4% | -$167K |
|
|
MTOR
1766
DELISTED
MERITOR, Inc.
MTOR
| $5.22M | 0.01% |
253,800
-617,900
| -71% | -$13M |
|
|
OTIC
1767
DELISTED
Otonomy, Inc.
OTIC
| $5.22M | 0.01% |
1,354,800
+338,100
| +33% | +$1.41M |
|
|
PHIIK
1768
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
| $5.19M | 0.01% |
510,000
+73,200
| +17% | +$846K |
|
|
CDR
1769
DELISTED
Cedar Realty Trust, Inc
CDR
| $5.18M | 0.01% |
166,399
-16,052
| -9% | -$443K |
|
1770
TTM Technologies
TTMI
$10.6B
| $5.18M | 0.01% |
+293,869
| New | +$4.91M |
|
1771
Rocket Pharmaceuticals
RCKT
$343M
| $5.17M | 0.01% |
263,645
+95,970
| +57% | +$1.82M |
|
|
EXAS
1772
DELISTED
Exact Sciences
EXAS
| $5.16M | 0.01% |
+86,300
| New | +$4.64M |
|
|
CTLP
1773
DELISTED
Cantaloupe
CTLP
| $5.16M | 0.01% |
368,500
+128,800
| +54% | +$1.47M |
|
1774
Applied Industrial Technologies
AIT
$12.4B
| $5.14M | 0.01% |
73,250
-11,850
| -14% | -$840K |
|
1775
RF Industries
RFIL
$116M
| $5.11M | 0.01% |
705,302
-30,098
| -4% | -$188K |
|
Similar funds
Renaissance Technologies's Q2 2018 Portfolio in Review
As of Q2 2018, Renaissance Technologies held 3,750 positions worth $91.7B, up 0.34% from $91.4B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies withdrew a net $3.9B in Q2 2018, closing 524 positions and reducing 1,111 holdings. Its most notable exit was Booking.com, an estimated $519M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
Against the trend, Renaissance Technologies opened a new position in Apple worth $707M.
- Renaissance Technologies's largest Q2 2018 buy was Apple: 15,275,332 shares worth $707M.
- Renaissance Technologies added most to Johnson & Johnson in Q2 2018, an estimated $306M increase.
- Renaissance Technologies's biggest Q2 2018 reduction was Home Depot, cutting an estimated $596M.
- Renaissance Technologies fully exited Booking.com in Q2 2018, selling an estimated $519M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $91.7B portfolio in Q2 2018.
- Renaissance Technologies opened 412 new positions and closed 524 in Q2 2018.
- Renaissance Technologies's portfolio value rose 0.34% quarter-over-quarter to $91.7B.
Based on Renaissance Technologies's 13F filing for Q2 2018, filed 13 Aug 2018.